JBIO vs MLTX: stock comparison and AI forecast
Jade Biosciences, Inc. (JBIO) and Moonlake Immunotherapeutics (MLTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
JBIO Jade Biosciences, Inc.
- Price
- $15.07 -37.8% · 6M
- Market Cap
- $958M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MLTX Moonlake Immunotherapeutics
- Price
- $10.80 -37.2% · 6M
- Market Cap
- $919M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- JBIO and MLTX have similar market capitalizations ($958M and $919M).
- Over the last six months MLTX returned -37.2% and JBIO -37.8%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | JBIO | MLTX |
|---|---|---|
| Market Cap | $958M | $919M |
| P/B Ratio | 2.18x | – |
| EPS | $-3.00 | $-3.33 |
| Book Value/Share | $6.92 | – |
| FCF/Share | – | $-2.87 |
Profitability & Margins
| Metric | JBIO | MLTX |
|---|---|---|
| ROE | -42.9% | – |
| ROA | -40.0% | – |
| ROIC | -41.9% | – |
| Tax Rate | -0.1% | -0.6% |
Financial Health
| Metric | JBIO | MLTX |
|---|---|---|
| Current Ratio | 14.93x | 9.13x |
| D/E Ratio | 0.07x | – |
| Financial Leverage | 1.07x | – |
| Interest Coverage | – | -37.0x |
| Working Capital | $440M | $475M |
Cash Flow
| Metric | JBIO | MLTX |
|---|---|---|
| Operating Cash Flow | -$124M | -$244M |
| Free Cash Flow | – | -$244M |
| Capital Spending | – | $0.00M |
Income Statement
| Metric | JBIO | MLTX |
|---|---|---|
| Operating Income | -$185M | -$277M |
| Net Income | -$189M | – |
| R&D Expense | $157M | $230M |
Dividend & Shareholder Information
| Metric | JBIO | MLTX |
|---|---|---|
| Shares Outstanding | 64M | 85M |
JBIO vs MLTX: stock comparison and AI forecast
Which is bigger, JBIO or MLTX?
JBIO and MLTX have similar market capitalizations ($958M and $919M).
Which stock performed better over the last six months, JBIO or MLTX?
Over the last six months MLTX returned -37.2% and JBIO -37.8%.
Which one does Intratio's AI model rank higher, JBIO or MLTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.